Glenmede Trust’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-50
| Closed | – | – | 2389 |
|
|
2020
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 2617 |
|
|
2020
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 2668 |
|
|
2020
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 3077 |
|
|
2019
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 3158 |
|
|
2019
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 3154 |
|
|
2019
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 3212 |
|
|
2019
Q1 | $0 | Buy |
+50
| New | – | ﹤0.01% | 3213 |
|
|
2018
Q2 | – | Sell |
-250
| Closed | -$3K | – | 2390 |
|
|
2018
Q1 | $3K | Hold |
250
| – | – | ﹤0.01% | 2540 |
|
|
2017
Q4 | $3K | Sell |
250
-300
| -55% | -$3.6K | ﹤0.01% | 2540 |
|
|
2017
Q3 | $4K | Buy |
550
+50
| +10% | +$364 | ﹤0.01% | 2427 |
|
|
2017
Q2 | $10K | Hold |
500
| – | – | ﹤0.01% | 2129 |
|
|
2017
Q1 | $10K | Hold |
500
| – | – | ﹤0.01% | 2129 |
|
|
2016
Q4 | $7K | Buy |
+500
| New | +$7K | ﹤0.01% | 2183 |
|